Healthy Skepticism Library item: 15999

Warning: This library includes all items relevant to health product marketing that we are aware of regardless of quality. Often we do not agree with all or part of the contents.

Publication type: Journal Article

Rimonabant: marketing authorization suspended... at last: withdrawal. Half-measures.
Prescrire Int 2009 Apr; 18:(100):16
http://www.ncbi.nlm.nih.gov/pubmed/19585720

Abstract:

Marketing authorization was granted for rimonabant on the basis of shaky data and despite poorly documented dangers. It took the EMEA 2 years to take action, by advising practitioners not to prescribe this drug.